Press Releases

November 16, 2020

PROMIS NEUROSCIENCES COMPLETES OFFERING OF SPECIAL WARRANTS

November 11, 2020

ProMIS Neurosciences Announces Third Quarter 2020 Results

Press Archives

In the News

November 4, 2020

Pharma Boardroom – Aducanumab edges closer to Potential Approval: Next up, the Advisory Committee meeting

September 23, 2020

Pharma Boardroom – Aducanumab: On the Regulatory Home Stretch in the USA

News Archives

Podcasts

Presentations

January 27, 2020

Sachs Neuroscience Innovation Forum Presentation

November 6, 2019

ProMIS Neurosciences: “Best in Class” therapy for misfolded protein diseases, based on a proprietary discovery platform

Presentations Archives

Videos

November 6, 2019

ProMIS Neurosciences: “Best in Class” therapy for misfolded protein diseases, based on a proprietary discovery platform

August 6, 2019

Dr. James Kupiec’s update from AAIC 2019: Demonstrating Early Proof-of-Concept with Biomarkers and Focused Patient Populations

July 18, 2019

ProMIS Neurosciences Highlights Data for PMN310 at AAIC 2019 

Video Archives